Abstract
BackgroundTo assess the effect of baricitinib on patient-reported outcomes (PROs) in patients with active rheumatoid arthritis and an inadequate response to methotrexate (MTX).MethodsIn this double-blind phase 3 study, patients were...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have